{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:51:08Z","timestamp":1790941868636,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.reprotox.2017.03.015","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:46:08Z","timestamp":1490921168000},"page":"297-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Intramuscularly administered herpes zoster subunit vaccine has no effects on fertility, pre- and post-natal development in Sprague-Dawley rats"],"prefix":"10.1016","volume":"69","author":[{"given":"Lawrence","family":"Segal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Fochesato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Gar\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Destexhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2017.03.015_bib0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM200003023420906","article-title":"Neurologic complications of the reactivation of varicella-zoster virus","volume":"342","author":"Gilden","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0010","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1056\/NEJMp058091","article-title":"Aging immunity, and the varicella-zoster virus","volume":"352","author":"Arvin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archinte.1982.00340150091017","article-title":"Immune responses to varicella-zoster in the aged","volume":"142","author":"Burke","year":"1982","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0020","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0025","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1212\/WNL.30.6.582","article-title":"Selective decline in cellular immune response to varicella-zoster in the elderly","volume":"30","author":"Miller","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2017.03.015_bib0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7015-7-26","article-title":"Varicella vaccination in Europe \u2212 taking the practical approach","volume":"7","author":"Bonanni","year":"2009","journal-title":"BMC Med."},{"issue":"Suppl 1","key":"10.1016\/j.reprotox.2017.03.015_bib0035","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1386-6532(10)70002-0","article-title":"Advances in the understanding of the pathogenesis and epidemiology of herpes zoster","volume":"48","author":"Gershon","year":"2010","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0040","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.reprotox.2017.03.015_bib0050","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0055","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0060","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0065","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0070","doi-asserted-by":"crossref","first-page":"9481","DOI":"10.1128\/JVI.00533-06","article-title":"Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection","volume":"80","author":"Berarducci","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0912373107","article-title":"Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection","volume":"107","author":"Berarducci","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.mi.44.100190.000423","article-title":"Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking","volume":"44","author":"Grose","year":"1990","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1086\/515638","article-title":"Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis","volume":"178","author":"Kimura","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0090","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1086\/511274","article-title":"Rapid effector function of varicella-zoster virus glycoprotein I-specific CD4+ T cells many decades after primary infection","volume":"195","author":"Malavige","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0095","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2249.2008.03633.x","article-title":"Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors","volume":"152","author":"Malavige","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0100","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1517\/14712598.4.7.1129","article-title":"Taking a toll on human disease: toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents","volume":"4","author":"Baldridge","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0105","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0110","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.146.2.431","article-title":"Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex","volume":"146","author":"Kensil","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0115","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1080\/21645515.2016.1154247","article-title":"Comparative preclinical evaluation of AS01 versus other Adjuvant Systems in a candidate herpes zoster glycoprotein E subunit vaccine","volume":"12","author":"Fochesato","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems","volume":"10","author":"Gar\u00e7on","year":"2011","journal-title":"Expert Rev. Vacc."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0125","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4049\/jimmunol.1400948","article-title":"Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells","volume":"193","author":"Didierlaurent","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jat.3329","article-title":"Nonclinical safety assessment of single and repeated administration of gE\/AS01 zoster vaccine in rabbits","volume":"37","author":"Giordano","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0135","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/infdis\/jit365","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults>=50 years of age","volume":"208","author":"Chlibek","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0140","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2014.01.019","article-title":"Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study","volume":"32","author":"Chlibek","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.reprotox.2017.03.015_bib0145","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.4161\/hv.24269","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ\/su): A phase-I open-label study in Japanese adults","volume":"9","author":"Lal","year":"2013","journal-title":"Hum. Vacc. Immunother."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0150","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/infdis\/jis497","article-title":"A phase 1\/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein E subunit vaccine candidate in young and older adults","volume":"206","author":"Leroux-Roels","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/jrf.0.0070185","article-title":"Observations on amount and distribution of prenatal mortality in a strain of albino rats","volume":"7","author":"Harper","year":"1964","journal-title":"J. Reprod. Fertil."},{"key":"10.1016\/j.reprotox.2017.03.015_bib0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vascn.2011.12.001","article-title":"Developmental and reproductive toxicity testing of vaccines","volume":"65","author":"Barrow","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.reprotox.2017.03.015_bib0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/bdrb.20201","article-title":"An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies","volume":"86","author":"Pentsuk","year":"2009","journal-title":"Birth Defects Res. B: Dev. Reprod. Toxicol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623817301661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623817301661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:47:45Z","timestamp":1760190465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623817301661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":33,"alternative-id":["S0890623817301661"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2017.03.015","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intramuscularly administered herpes zoster subunit vaccine has no effects on fertility, pre- and post-natal development in Sprague-Dawley rats","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2017.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}